Total Funding
82
79
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
283006
Midway Pharmaceuticals is a developer of specialty drugs designed to provide beneficial effects in the treatment of gastrointestinal.
- John Alverdy: Scientific Founder
Harry Arader: DirectorPast Role: RNAgri, Chief Executive Officer
About the Company
Midway Pharmaceuticals is a developer of specialty drugs designed to provide beneficial effects in the treatment of gastrointestinal and systemic diseases. The company's specialty drugs focus on finding high molecular weight polymers that can be consumed orally and inhibit the pathogenic behavior of bacteria in the GI tract, enhance gut
barrier function and promote gastrointestinal healing, enabling healthcare institutions to avail enhanced drugs to protect people's guts from radiation damage and infection.
Women Founded
